Source-grounded facts extracted from CENTENE CORP's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Jesse N. Hunter departed as Executive Vice President and Chief Strategy Officer at CENTENE CORP.
“Centene Corporation (“Centene”) and Jesse N. Hunter, the former Executive Vice President and Chief Strategy Officer of Centene, have mutually agreed that Mr. Hunter’s last day will be November 5, 2021, rather than December 31, 2021.”
David L. Steward retired as Director at CENTENE CORP.
“On October 5, 2021, David L. Steward notified Centene Corporation (the “Company”) of his intention to retire from the Board of Directors, effective October 6, 2021.”
Jeffrey A. Schwaneke resigned as Executive Vice President of HealthCare Enterprises at CENTENE CORP.
“Centene Corporation (“Centene”) and Jeffrey A. Schwaneke, the former Executive Vice President of HealthCare Enterprises of Centene, mutually agreed that Mr. Schwaneke would resign from his employment with Centene effective as of September 22, 2021.”
Brent D. Layton was elected as President and Chief Operating Officer at CENTENE CORP.
“Brent D. Layton as the Company’s President and Chief Operating Officer”
Sarah M. London was appointed as Class III director at CENTENE CORP.
“Ms. London was appointed to serve on the Company’s Board of Directors.”
Sarah M. London was elected as Vice Chairman at CENTENE CORP.
“elected Sarah M. London as Vice Chairman of the Board of Directors of Centene Corporation”
Jesse Hunter resigned as Executive Vice President and Chief Strategy Officer at CENTENE CORP.
“Jesse Hunter, Executive Vice President and Chief Strategy Officer, notified the Company of his intent to resign from his position effective July 31, 2021, and will provide transition support continuing through December 31, 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.